Report Detail

Request for Sample of this report

Pharma & Healthcare Global Pets NSAIDs Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

  • RnM4655793
    • |
  • 05 December, 2025
    • |
  • Global
    • |
  • 114 Pages
    • |
  • GIR
    • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Pets NSAIDs market size was valued at US$ 483 million in 2024 and is forecast to a readjusted size of USD 712 million by 2031 with a CAGR of 5.8% during review period.
Veterinary nonsteroidal anti-inflammatory drugs (NSAIDs) are commonly used to control fever, pain, and other signs of inflammation in animals. Inflammation is the body"s response to irritation or injury and results in redness, warmth, swelling, and pain in the inflamed area.
According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%. The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly €6.5 billion. The 2023 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by year: pet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 43%.
This report is a detailed and comprehensive analysis for global Pets NSAIDs market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Pets NSAIDs market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Pets NSAIDs market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Pets NSAIDs market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Pets NSAIDs market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Pets NSAIDs
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Pets NSAIDs market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, Bayer, JandJ, GSK, Septodont, Roche, PerioChip, Mobic, Rimadyl, Vetprofen, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Pets NSAIDs market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Injection Type
Oral Type
Others
Market segment by Application
Pet Hospital
Pet Shop
Household Use
Major players covered
Merck
Bayer
JandJ
GSK
Septodont
Roche
PerioChip
Mobic
Rimadyl
Vetprofen
Novox
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Pets NSAIDs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Pets NSAIDs, with price, sales quantity, revenue, and global market share of Pets NSAIDs from 2020 to 2025.
Chapter 3, the Pets NSAIDs competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pets NSAIDs breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Pets NSAIDs market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Pets NSAIDs.
Chapter 14 and 15, to describe Pets NSAIDs sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Pets NSAIDs Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Injection Type
    • 1.3.3 Oral Type
    • 1.3.4 Others
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Pets NSAIDs Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Pet Hospital
    • 1.4.3 Pet Shop
    • 1.4.4 Household Use
  • 1.5 Global Pets NSAIDs Market Size & Forecast
    • 1.5.1 Global Pets NSAIDs Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global Pets NSAIDs Sales Quantity (2020-2031)
    • 1.5.3 Global Pets NSAIDs Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 Merck
    • 2.1.1 Merck Details
    • 2.1.2 Merck Major Business
    • 2.1.3 Merck Pets NSAIDs Product and Services
    • 2.1.4 Merck Pets NSAIDs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Merck Recent Developments/Updates
  • 2.2 Bayer
    • 2.2.1 Bayer Details
    • 2.2.2 Bayer Major Business
    • 2.2.3 Bayer Pets NSAIDs Product and Services
    • 2.2.4 Bayer Pets NSAIDs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Bayer Recent Developments/Updates
  • 2.3 JandJ
    • 2.3.1 JandJ Details
    • 2.3.2 JandJ Major Business
    • 2.3.3 JandJ Pets NSAIDs Product and Services
    • 2.3.4 JandJ Pets NSAIDs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 JandJ Recent Developments/Updates
  • 2.4 GSK
    • 2.4.1 GSK Details
    • 2.4.2 GSK Major Business
    • 2.4.3 GSK Pets NSAIDs Product and Services
    • 2.4.4 GSK Pets NSAIDs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 GSK Recent Developments/Updates
  • 2.5 Septodont
    • 2.5.1 Septodont Details
    • 2.5.2 Septodont Major Business
    • 2.5.3 Septodont Pets NSAIDs Product and Services
    • 2.5.4 Septodont Pets NSAIDs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Septodont Recent Developments/Updates
  • 2.6 Roche
    • 2.6.1 Roche Details
    • 2.6.2 Roche Major Business
    • 2.6.3 Roche Pets NSAIDs Product and Services
    • 2.6.4 Roche Pets NSAIDs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Roche Recent Developments/Updates
  • 2.7 PerioChip
    • 2.7.1 PerioChip Details
    • 2.7.2 PerioChip Major Business
    • 2.7.3 PerioChip Pets NSAIDs Product and Services
    • 2.7.4 PerioChip Pets NSAIDs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 PerioChip Recent Developments/Updates
  • 2.8 Mobic
    • 2.8.1 Mobic Details
    • 2.8.2 Mobic Major Business
    • 2.8.3 Mobic Pets NSAIDs Product and Services
    • 2.8.4 Mobic Pets NSAIDs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 Mobic Recent Developments/Updates
  • 2.9 Rimadyl
    • 2.9.1 Rimadyl Details
    • 2.9.2 Rimadyl Major Business
    • 2.9.3 Rimadyl Pets NSAIDs Product and Services
    • 2.9.4 Rimadyl Pets NSAIDs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 Rimadyl Recent Developments/Updates
  • 2.10 Vetprofen
    • 2.10.1 Vetprofen Details
    • 2.10.2 Vetprofen Major Business
    • 2.10.3 Vetprofen Pets NSAIDs Product and Services
    • 2.10.4 Vetprofen Pets NSAIDs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 Vetprofen Recent Developments/Updates
  • 2.11 Novox
    • 2.11.1 Novox Details
    • 2.11.2 Novox Major Business
    • 2.11.3 Novox Pets NSAIDs Product and Services
    • 2.11.4 Novox Pets NSAIDs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.11.5 Novox Recent Developments/Updates

3 Competitive Environment: Pets NSAIDs by Manufacturer

  • 3.1 Global Pets NSAIDs Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global Pets NSAIDs Revenue by Manufacturer (2020-2025)
  • 3.3 Global Pets NSAIDs Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of Pets NSAIDs by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 Pets NSAIDs Manufacturer Market Share in 2024
    • 3.4.3 Top 6 Pets NSAIDs Manufacturer Market Share in 2024
  • 3.5 Pets NSAIDs Market: Overall Company Footprint Analysis
    • 3.5.1 Pets NSAIDs Market: Region Footprint
    • 3.5.2 Pets NSAIDs Market: Company Product Type Footprint
    • 3.5.3 Pets NSAIDs Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Pets NSAIDs Market Size by Region
    • 4.1.1 Global Pets NSAIDs Sales Quantity by Region (2020-2031)
    • 4.1.2 Global Pets NSAIDs Consumption Value by Region (2020-2031)
    • 4.1.3 Global Pets NSAIDs Average Price by Region (2020-2031)
  • 4.2 North America Pets NSAIDs Consumption Value (2020-2031)
  • 4.3 Europe Pets NSAIDs Consumption Value (2020-2031)
  • 4.4 Asia-Pacific Pets NSAIDs Consumption Value (2020-2031)
  • 4.5 South America Pets NSAIDs Consumption Value (2020-2031)
  • 4.6 Middle East & Africa Pets NSAIDs Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global Pets NSAIDs Sales Quantity by Type (2020-2031)
  • 5.2 Global Pets NSAIDs Consumption Value by Type (2020-2031)
  • 5.3 Global Pets NSAIDs Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global Pets NSAIDs Sales Quantity by Application (2020-2031)
  • 6.2 Global Pets NSAIDs Consumption Value by Application (2020-2031)
  • 6.3 Global Pets NSAIDs Average Price by Application (2020-2031)

7 North America

  • 7.1 North America Pets NSAIDs Sales Quantity by Type (2020-2031)
  • 7.2 North America Pets NSAIDs Sales Quantity by Application (2020-2031)
  • 7.3 North America Pets NSAIDs Market Size by Country
    • 7.3.1 North America Pets NSAIDs Sales Quantity by Country (2020-2031)
    • 7.3.2 North America Pets NSAIDs Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe Pets NSAIDs Sales Quantity by Type (2020-2031)
  • 8.2 Europe Pets NSAIDs Sales Quantity by Application (2020-2031)
  • 8.3 Europe Pets NSAIDs Market Size by Country
    • 8.3.1 Europe Pets NSAIDs Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe Pets NSAIDs Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific Pets NSAIDs Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific Pets NSAIDs Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific Pets NSAIDs Market Size by Region
    • 9.3.1 Asia-Pacific Pets NSAIDs Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific Pets NSAIDs Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America Pets NSAIDs Sales Quantity by Type (2020-2031)
  • 10.2 South America Pets NSAIDs Sales Quantity by Application (2020-2031)
  • 10.3 South America Pets NSAIDs Market Size by Country
    • 10.3.1 South America Pets NSAIDs Sales Quantity by Country (2020-2031)
    • 10.3.2 South America Pets NSAIDs Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa Pets NSAIDs Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa Pets NSAIDs Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa Pets NSAIDs Market Size by Country
    • 11.3.1 Middle East & Africa Pets NSAIDs Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa Pets NSAIDs Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 Pets NSAIDs Market Drivers
  • 12.2 Pets NSAIDs Market Restraints
  • 12.3 Pets NSAIDs Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Pets NSAIDs and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Pets NSAIDs
  • 13.3 Pets NSAIDs Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Pets NSAIDs Typical Distributors
  • 14.3 Pets NSAIDs Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Pets NSAIDs. Industry analysis & Market Report on Pets NSAIDs is a syndicated market report, published as Global Pets NSAIDs Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031. It is complete Research Study and Industry Analysis of Pets NSAIDs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo